Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals

 
• By Derrick Gingery
diversity
Sponsors are hoping clinical trial diversity guidance updates will include more clarity on FDA actions when enrollment goals are missed. • Source: Shutterstock

More from Diversity & Inclusion

More from Clinical Trials